Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases
Brain metastases are an increasing burden among breast cancer patients, particularly for those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the pathophysiology of brain metastases and preclinical validation of therapies has relied almost exclusively on intracardiac injectio...
Main Authors: | , , , , , , , , , , , , , |
---|---|
格式: | Article |
語言: | English |
出版: |
Frontiers Media S.A.
2017-11-01
|
叢編: | Frontiers in Oncology |
主題: | |
在線閱讀: | http://journal.frontiersin.org/article/10.3389/fonc.2017.00252/full |